APA citiranje

Dultz, L. A., Dhar, S., Ogilvie, J. B., Heller, K. S., Bar-Sagi, D., & Patel, K. N. (2013). CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER.

Citação norma Chicago

Dultz, Linda A., Shumon Dhar, Jennifer B. Ogilvie, Keith S. Heller, Dafna Bar-Sagi, and Kepal N. Patel. CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER. 2013.

MLA citiranje

Dultz, Linda A., et al. CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER. 2013.